相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Severe Acute Kidney Injury Due to Nivolumab/Ipilimumab-induced Granulomatosis and Fibrinoid Vascular Necrosis
Fermin Person et al.
JOURNAL OF IMMUNOTHERAPY (2020)
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House et al.
CLINICAL CANCER RESEARCH (2020)
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Michael Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Recruitment of CXCR3+ T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity
Alexandra Audemard-Verger et al.
JOURNAL OF AUTOIMMUNITY (2019)
Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint innioitors
Alexander J. Gallan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
William Damsky et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach
Laura Martinez Valenzuela et al.
CLINICAL KIDNEY JOURNAL (2019)
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Harish Seethapathy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Chemokine and Cytokine Cascade Caused by Skewing of the Th1-Th2 Balance Is Associated with High Intracranial Pressure in HIV-Associated Cryptococcal Meningitis
Lijun Xu et al.
MEDIATORS OF INFLAMMATION (2019)
Dampening of CD8+T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Antoine Neel et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Omar Mamlouk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Vasculitis associated with immune checkpoint inhibitors-a systematic review
Anisha Daxini et al.
CLINICAL RHEUMATOLOGY (2018)
Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
Emma E. van Daalen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
Xavier Bossuyt et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis
Hui Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Immune checkpoint dysfunction in large and medium vessel vasculitis
Ryu Watanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im et al.
NATURE (2016)
Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition
Rob R. H. van den Brom et al.
RHEUMATOLOGY (2016)
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
Rachel B. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Drug-Induced Glomerular Disease: Immune-Mediated Injury
Jonathan J. Hogan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis
Olumide Olatubosun Rowaiye et al.
CLINICAL KIDNEY JOURNAL (2015)
Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Have Defective Treg Cell Function Exacerbated by the Presence of a Suppression-Resistant Effector Cell Population
Meghan E. Free et al.
ARTHRITIS AND RHEUMATISM (2013)
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis
Aleeza J. Roth et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis
J. Charles Jennette et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rituximab Treatment for Vasculitis
David Jayne
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Histopathologic Classification of ANCA-Associated Glomerulonephritis
Annelies E. Berden et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
Benjamin Wilde et al.
ARTHRITIS RESEARCH & THERAPY (2010)
CTLA-4 blockade increases IFNγ-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
Chrysoula I. Liakou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement
Robert A. F. de Lind van Wijngaarden et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
An index for renal outcome in ANCA-associated glomerulonephritis
CE Vergunst et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Henoch-Schonlein Purpura in adults: Outcome and prognostic factors
E Pillebout et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits
M Haas et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication
JE Gunton et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
分享论文
